October 23, 2022 — Meeting with a medical physicist who can explain how radiation therapy is planned and delivered reduces patient anxiety and increases patient satisfaction throughout the treatment process, according to a new study published today in the International Journal of Radiation Oncology • Biology • Physics.

October 23, 2022 — A new randomized study confirms that men with high-risk prostate cancer can be treated with five versus eight weeks of radiation therapy. The phase III clinical trial is the first to confirm the safety and efficacy of a moderately shortened course of radiation exclusively for patients with high-risk disease.

October 21, 2022 — Varian, a Siemens Healthineers company, is highlighting its portfolio of intelligent, end-to-end imaging and cancer care technologies and services during the 2022 American Society for Radiation Oncology (ASTRO) annual meeting taking place from October 23-26 in San Antonio, Texas. 

October 21, 2022 — ViewRay, Inc. (NASDAQ: VRAY) today announced that the company's MRIdian MRI-Guided Radiation Therapy System will be featured at the 64th Annual Meeting of the American Society for Radiation Oncology (ASTRO), being held October 23-26, 2022, at the Henry B. González Convention Center in San Antonio, Texas.

October 21, 2022 — A new study finds that sexual side effects of cancer treatment are discussed far less frequently with female patients than with male patients, even when the treatment directly affects sex organs.

October 20, 2022 — A new highly selective PET imaging agent can detect the presence of overexpressed monoamine oxidase-B (MAO-B) in cognitively unimpaired individuals with high beta a

October 20, 2022 — A large study on the impact of long COVID found increased rates of health system use 2 months after infection with SARS-CoV-2, which has implications for health care delivery in the future.

October 20, 2022 — A cohort study of more than one million people has found that most persons screened for lung cancer meet U.S. Preventative Services Task Force (USPSTF) criteria, but men, persons who formerly smoked, and younger eligible patients are less likely to be screened. Adherence to follow-up screening was also poor.

October 20, 2022 — Royal Philips, a global leader in health technology, announced two new advances in MR-only workflows to advance head and neck cancer radiotherapy imaging and simulation.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now